Complete financial analysis of BrightSpring Health Services, Inc. Common Stock (BTSG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of BrightSpring Health Services, Inc. Common Stock, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
You may be interested
- RADA Electronic Industries Ltd. (RADA) Income Statement Analysis – Financial Results
- Zhejiang Yangfan New Materials Co., Ltd. (300637.SZ) Income Statement Analysis – Financial Results
- LeanLife Health Inc. (LLP.CN) Income Statement Analysis – Financial Results
- Mangalore Chemicals & Fertilizers Limited (MANGCHEFER.BO) Income Statement Analysis – Financial Results
- BENEFIT JAPAN Co., Ltd. (3934.T) Income Statement Analysis – Financial Results
BrightSpring Health Services, Inc. Common Stock (BTSG)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.brightspringhealth.com
About BrightSpring Health Services, Inc. Common Stock
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. BrightSpring Health Services, Inc. was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. The company was founded in 1974 and is based in Louisville, Kentucky.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 8.83B | 7.72B | 6.70B | 5.58B | 4.53B | 2.54B |
| Cost of Revenue | 7.39B | 6.37B | 5.45B | 4.53B | 3.69B | 2.16B |
| Gross Profit | 1.43B | 1.35B | 1.25B | 1.05B | 833.91M | 375.91M |
| Gross Profit Ratio | 16.24% | 17.54% | 18.64% | 18.79% | 18.43% | 14.82% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.29B | 1.06B | 1.01B | 774.93M | 696.36M | 301.06M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.29B | 1.06B | 1.01B | 774.93M | 696.36M | 301.06M |
| Cost & Expenses | 8.68B | 7.42B | 6.46B | 5.31B | 4.39B | 2.46B |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 324.59M | 233.58M | 165.32M | 138.95M | 166.89M | 74.61M |
| Depreciation & Amortization | 202.34M | 203.97M | 199.16M | 181.50M | 154.87M | 81.17M |
| EBITDA | 349.52M | 500.00M | 433.34M | 346.69M | 292.41M | 156.02M |
| EBITDA Ratio | 3.96% | 6.48% | 6.47% | 8.16% | 6.46% | 6.15% |
| Operating Income | 147.18M | 296.03M | 234.18M | 273.81M | 137.55M | 74.85M |
| Operating Income Ratio | 1.67% | 3.83% | 3.50% | 4.91% | 3.04% | 2.95% |
| Total Other Income/Expenses | -324.59M | -341.78M | -165.32M | -138.95M | -241.13M | -85.68M |
| Income Before Tax | -177.41M | -45.75M | 68.86M | 26.24M | -103.58M | -10.83M |
| Income Before Tax Ratio | -2.01% | -0.59% | 1.03% | 0.47% | -2.29% | -0.43% |
| Income Tax Expense | -20.58M | 8.47M | 17.60M | 5.09M | -32.49M | -3.21M |
| Net Income | -154.60M | -53.91M | 49.80M | 20.81M | -72.38M | -7.62M |
| Net Income Ratio | -1.75% | -0.70% | 0.74% | 0.37% | -1.60% | -0.30% |
| EPS | -0.90 | -0.31 | 0.29 | 2.79 | -10.26 | -1.57 |
| EPS Diluted | -0.90 | -0.31 | 0.29 | 2.78 | -10.26 | -1.57 |
| Weighted Avg Shares Out | 171.19M | 171.19M | 171.19M | 7.45M | 7.06M | 4.85M |
| Weighted Avg Shares Out (Dil) | 171.19M | 171.19M | 171.19M | 7.49M | 7.06M | 4.85M |
BrightSpring Health Services Announces Onco360® Has Been Selected as a Partner for Several New Drugs
LOUISVILLE, Ky., Nov. 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud of its specialty pharmacy partner, Onco360®, for being selected as the national pharmacy partner for multiple medications approved to treat...
BrightSpring Health Services, Inc. to Participate in Two Upcoming Investor Conferences
LOUISVILLE, Ky., Nov. 21, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that Company management will participate at two upcoming virtual investor conferences.
BrightSpring Health Services Announces CareMed Was Selected as a National Specialty Pharmacy Partner for Leqembi®
LOUISVILLE, Ky., Nov. 06, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud that CareMed, a BrightSpring company and leading independent Specialty Pharmacy, was selected by Eisai to be the national specialty pharmacy...
BrightSpring Health Services, Inc. (BTSG) Q3 2024 Earnings Call Transcript
BrightSpring Health Services, Inc. (NASDAQ:BTSG ) Q3 2024 Earnings Conference Call November 1, 2024 8:30 AM ET Company Participants Jennifer Phipps - Chief Accounting Officer Jon Rousseau - President & Chief Executive Officer Jim Mattingly - Chief Financial Officer Conference...
BrightSpring Health Services, Inc. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Guidance
LOUISVILLE, Ky., Nov. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the third quarter ended September...
Global IPO Activity Picking Up But Continues To Lag Other Post-COVID Years
Global IPO activity is recovering but remains below recent years, with 326 IPOs in Q3 2024 totaling $23.32 billion, the lowest since Q1 2019. US IPO activity has increased steadily, with 36 IPOs in Q3 2024, and $26.28 billion raised...
FMR LLC's Strategic Acquisition in BrightSpring Health Services Inc
On September 30, 2024, FMR LLC (Trades, Portfolio) made a significant addition to its investment portfolio by acquiring 18,498,153 shares of BrightSpring Health Services Inc (BTSG, Financial). This transaction, executed at a price of $14.68 per share, reflects a strategic...
BrightSpring Health Services, Inc. to Announce Third Quarter 2024 Financial Results on November 1, 2024
LOUISVILLE, Ky., Oct. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its third quarter 2024 financial results on Friday, November 1, 2024, prior to the Company's...
BrightSpring Health Services, Inc. Welcomes Dr. Steve Miller to Board of Directors
LOUISVILLE, Ky., Sept. 30, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “the Company”) (NASDAQ: BTSG), a leading provider of home- and community-based health services for complex populations, today announced that Dr. Steve Miller was appointed as a Class...
Levi & Korsinsky Investigates Possible Securities Fraud Violations by BrightSpring Health Services, Inc. (BTSG)
NEW YORK, NY / ACCESSWIRE / September 18, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of BrightSpring Health Services, Inc. ("BrightSpring Health Services, Inc.") (NASDAQ:BTSG) concerning possible violations of federal securities laws. BrightSpring conducted...
Source: https://incomestatements.info
Category: Stock Reports